file1,
file2, etc. all in the same folder or directory;
first, locate one of the files with the [Browse...] button. Then alter the
file path in the box above to include '*' character (eg. file*).
Wildcard '?' to blanket only one character works too.| Historiographs |
Grand Totals: LCS 17722, GCS 106366, CR 136943 Collection span: 1963 - 2012 | |
| Word(i) List (4568) Word count: 24159, All words count: 34321 | ||
| # | Word | Recs | TLCS | TGCS |
|---|---|---|---|---|
| 1001 | 1ST | 3 | 15 | 152 |
| 1002 | 20-YEAR | 3 | 0 | 54 |
| 1003 | ACCELERATED | 3 | 0 | 4 |
| 1004 | ACHIEVE | 3 | 1 | 9 |
| 1005 | ACHIEVED | 3 | 1 | 25 |
| 1006 | ACHIEVEMENT | 3 | 34 | 74 |
| 1007 | AGE | 3 | 2 | 37 |
| 1008 | AID | 3 | 10 | 36 |
| 1009 | ALLELES | 3 | 7 | 51 |
| 1010 | ALLO-AND | 3 | 4 | 14 |
| 1011 | ALLOCATION | 3 | 11 | 93 |
| 1012 | ALLOSTIMULATORY | 3 | 29 | 101 |
| 1013 | ALTERATION | 3 | 0 | 13 |
| 1014 | ALTERNATE-DAY | 3 | 7 | 95 |
| 1015 | ALTERS | 3 | 35 | 148 |
| 1016 | AMELIORATES | 3 | 9 | 77 |
| 1017 | ANASTOMOSIS | 3 | 2 | 16 |
| 1018 | ANERGY | 3 | 57 | 322 |
| 1019 | ANESTHESIA | 3 | 1 | 4 |
| 1020 | ANIMAL-MODEL | 3 | 9 | 115 |
| 1021 | ANTIBODY-PRODUCTION | 3 | 3 | 26 |
| 1022 | ANTIDONOR | 3 | 33 | 82 |
| 1023 | ANTIGEN-INDUCED | 3 | 1 | 29 |
| 1024 | ANTIINFLAMMATORY | 3 | 17 | 152 |
| 1025 | ANTILYMPHOCYTE-SERUM | 3 | 12 | 36 |
| 1026 | APLASIA | 3 | 1 | 21 |
| 1027 | AUTOTRANSPLANTATION | 3 | 6 | 73 |
| 1028 | AXONAL | 3 | 41 | 340 |
| 1029 | BARRIERS | 3 | 1 | 37 |
| 1030 | BINDING | 3 | 6 | 147 |
| # | Word | Recs | TLCS | TGCS |
| 1031 | BIOPSY | 3 | 7 | 134 |
| 1032 | BLEEDING | 3 | 6 | 69 |
| 1033 | BLOOD-GROUP | 3 | 2 | 66 |
| 1034 | BLOOD-PRESSURE | 3 | 3 | 121 |
| 1035 | BRAIN | 3 | 1 | 84 |
| 1036 | BRIEF | 3 | 18 | 77 |
| 1037 | CAPACITY | 3 | 15 | 192 |
| 1038 | CARCINOMA | 3 | 0 | 64 |
| 1039 | CARDIOVASCULAR | 3 | 5 | 53 |
| 1040 | CD25 | 3 | 4 | 37 |
| 1041 | CD34 | 3 | 10 | 94 |
| 1042 | CD95L | 3 | 26 | 179 |
| 1043 | CELL-MEDIATED | 3 | 13 | 110 |
| 1044 | CHEMISTRY | 3 | 72 | 1381 |
| 1045 | CHICKEN | 3 | 0 | 13 |
| 1046 | CHILDHOOD | 3 | 2 | 86 |
| 1047 | CIRRHOSIS | 3 | 10 | 2250 |
| 1048 | CLINICAL-RESULTS | 3 | 4 | 76 |
| 1049 | CLINICOPATHOLOGICAL | 3 | 41 | 108 |
| 1050 | COAGULATION | 3 | 13 | 64 |
| 1051 | COLUMN | 3 | 16 | 230 |
| 1052 | COMMON | 3 | 15 | 172 |
| 1053 | COMPARATIVE-STUDY | 3 | 7 | 122 |
| 1054 | COMPLEXES | 3 | 30 | 1035 |
| 1055 | COMPOSITION | 3 | 0 | 184 |
| 1056 | COMPOUNDS | 3 | 5 | 69 |
| 1057 | CONCENTRATION | 3 | 0 | 11 |
| 1058 | CONCEPT | 3 | 29 | 68 |
| 1059 | CONSENSUS | 3 | 16 | 198 |
| 1060 | CONTINUED | 3 | 29 | 113 |
| # | Word | Recs | TLCS | TGCS |
| 1061 | CONTRIBUTE | 3 | 26 | 140 |
| 1062 | CONTRIBUTIONS | 3 | 23 | 75 |
| 1063 | CORRELATIONS | 3 | 62 | 117 |
| 1064 | COSTIMULATORY | 3 | 40 | 247 |
| 1065 | CYCLOSPORINE-BASED | 3 | 18 | 121 |
| 1066 | CYCLOSPORINE-PREDNISONE | 3 | 11 | 172 |
| 1067 | CYTOTOXICITY | 3 | 6 | 109 |
| 1068 | DAYS | 3 | 11 | 80 |
| 1069 | DECREASES | 3 | 10 | 401 |
| 1070 | DELETERIOUS | 3 | 3 | 352 |
| 1071 | DELIVERY | 3 | 0 | 24 |
| 1072 | DETERMINANT | 3 | 4 | 137 |
| 1073 | DEVELOPED | 3 | 4 | 43 |
| 1074 | DIABETIC-PATIENTS | 3 | 5 | 81 |
| 1075 | DISCORDANT | 3 | 2 | 14 |
| 1076 | DISORDER | 3 | 1 | 54 |
| 1077 | DISTINCT | 3 | 32 | 672 |
| 1078 | DOSE-DEPENDENT | 3 | 8 | 109 |
| 1079 | DOWN-REGULATION | 3 | 3 | 68 |
| 1080 | DRUG-INDUCED | 3 | 3 | 36 |
| 1081 | DRUG-MONITORING | 3 | 16 | 113 |
| 1082 | DRUG-THERAPY | 3 | 71 | 1612 |
| 1083 | DUCTOPENIC | 3 | 28 | 118 |
| 1084 | EFFECTIVENESS | 3 | 6 | 52 |
| 1085 | ENCEPHALOMYELITIS | 3 | 3 | 45 |
| 1086 | END | 3 | 0 | 3 |
| 1087 | END-STAGE | 3 | 3 | 86 |
| 1088 | ENHANCE | 3 | 16 | 45 |
| 1089 | ENHANCEMENT | 3 | 20 | 70 |
| 1090 | ENLARGEMENT | 3 | 10 | 68 |
| # | Word | Recs | TLCS | TGCS |
| 1091 | ENZYMES | 3 | 42 | 416 |
| 1092 | EQUINE | 3 | 7 | 31 |
| 1093 | ESTABLISH | 3 | 5 | 23 |
| 1094 | ESTABLISHING | 3 | 8 | 18 |
| 1095 | EVENT | 3 | 15 | 85 |
| 1096 | EVOLVING | 3 | 0 | 22 |
| 1097 | EXPOSURE | 3 | 8 | 146 |
| 1098 | EXPRESSING | 3 | 12 | 54 |
| 1099 | FACE | 3 | 0 | 35 |
| 1100 | FACILITATES | 3 | 4 | 21 |
| 1101 | FETAL-MATERNAL | 3 | 6 | 44 |
| 1102 | FISTULA | 3 | 9 | 101 |
| 1103 | FK506-BINDING | 3 | 22 | 325 |
| 1104 | FLAPS | 3 | 0 | 39 |
| 1105 | FLT-3 | 3 | 19 | 49 |
| 1106 | FOCAL | 3 | 0 | 41 |
| 1107 | FOLLOWED | 3 | 23 | 221 |
| 1108 | FORMATION | 3 | 0 | 3 |
| 1109 | FORMED | 3 | 37 | 591 |
| 1110 | FRONTIER | 3 | 14 | 125 |
| 1111 | FUNCTIONS | 3 | 0 | 25 |
| 1112 | GLOBULINS | 3 | 0 | 12 |
| 1113 | GM-CSF | 3 | 8 | 62 |
| 1114 | GRAFTED | 3 | 3 | 33 |
| 1115 | GRAIL | 3 | 3 | 28 |
| 1116 | GREEN | 3 | 4 | 55 |
| 1117 | GVH | 3 | 94 | 139 |
| 1118 | GVHD | 3 | 11 | 43 |
| 1119 | HEARTS | 3 | 10 | 114 |
| 1120 | HEMATOLYMPHOID | 3 | 98 | 150 |
| # | Word | Recs | TLCS | TGCS |
| 1121 | HEMATOPOIESIS | 3 | 0 | 3 |
| 1122 | HEMOPOIETIC | 3 | 24 | 113 |
| 1123 | HETEROTOPIC | 3 | 1 | 16 |
| 1124 | HIGHLY | 3 | 0 | 97 |
| 1125 | HISTOPATHOLOGIC | 3 | 2 | 8 |
| 1126 | HOLY | 3 | 3 | 28 |
| 1127 | HPLC | 3 | 33 | 193 |
| 1128 | HUMAN-KIDNEY | 3 | 1 | 76 |
| 1129 | HYBRIDIZATION | 3 | 24 | 137 |
| 1130 | HYPERTROPHY | 3 | 0 | 62 |
| 1131 | III | 3 | 15 | 179 |
| 1132 | IL-10 | 3 | 10 | 199 |
| 1133 | IL-2 | 3 | 3 | 41 |
| 1134 | IMMATURE | 3 | 18 | 82 |
| 1135 | IMMUNODEPRESSIVE | 3 | 4 | 22 |
| 1136 | IMMUNOREGULATORY | 3 | 15 | 36 |
| 1137 | IMPLANTATION | 3 | 4 | 23 |
| 1138 | INCREASE | 3 | 0 | 76 |
| 1139 | INDUCIBLE | 3 | 0 | 70 |
| 1140 | INFANTS | 3 | 9 | 139 |
| 1141 | INSITU | 3 | 9 | 101 |
| 1142 | INSUFFICIENCY | 3 | 2 | 55 |
| 1143 | INTERSTITIAL | 3 | 5 | 71 |
| 1144 | INTRARENAL | 3 | 7 | 119 |
| 1145 | ISCHEMIC | 3 | 1 | 69 |
| 1146 | JAPANESE | 3 | 4 | 25 |
| 1147 | JOINT | 3 | 0 | 2 |
| 1148 | LACK | 3 | 2 | 34 |
| 1149 | LANDMARKS | 3 | 21 | 43 |
| 1150 | LEADING | 3 | 30 | 262 |
| # | Word | Recs | TLCS | TGCS |
| 1151 | LECTURE | 3 | 4 | 117 |
| 1152 | LEFLUNOMIDE | 3 | 6 | 149 |
| 1153 | LESS | 3 | 3 | 12 |
| 1154 | LEUCOCYTE | 3 | 4 | 21 |
| 1155 | LIMITS | 3 | 0 | 12 |
| 1156 | LIPOSOMAL | 3 | 1 | 27 |
| 1157 | LIQUID-CHROMATOGRAPHIC | 3 | 9 | 297 |
| 1158 | LIVER-DISEASE | 3 | 11 | 427 |
| 1159 | LONG-SURVIVING | 3 | 8 | 33 |
| 1160 | LOWER | 3 | 29 | 117 |
| 1161 | MACROCHIMERISM | 3 | 17 | 57 |
| 1162 | MACROLIDES | 3 | 0 | 30 |
| 1163 | MAINTAIN | 3 | 5 | 16 |
| 1164 | MAINTAINED | 3 | 1 | 68 |
| 1165 | MALIGNANT | 3 | 0 | 51 |
| 1166 | MARKERS | 3 | 0 | 13 |
| 1167 | MARROW-AUGMENTED | 3 | 42 | 63 |
| 1168 | MASS-SPECTROMETRY | 3 | 3 | 447 |
| 1169 | MATRIX | 3 | 3 | 88 |
| 1170 | MATURATION | 3 | 2 | 102 |
| 1171 | MATURE | 3 | 20 | 426 |
| 1172 | MAY | 3 | 21 | 35 |
| 1173 | MEANS | 3 | 9 | 32 |
| 1174 | METABOLITE | 3 | 29 | 160 |
| 1175 | MICROEMULSION | 3 | 3 | 91 |
| 1176 | MICROVASCULAR | 3 | 7 | 72 |
| 1177 | MINIATURE | 3 | 13 | 82 |
| 1178 | MINIMIZATION | 3 | 1 | 14 |
| 1179 | MORTALITY | 3 | 0 | 106 |
| 1180 | MOUSE-LIVER | 3 | 82 | 295 |
| # | Word | Recs | TLCS | TGCS |
| 1181 | MUSCLE | 3 | 0 | 27 |
| 1182 | NATIVE | 3 | 0 | 7 |
| 1183 | NATURE | 3 | 5 | 52 |
| 1184 | NECROSIS | 3 | 0 | 21 |
| 1185 | NEED | 3 | 21 | 70 |
| 1186 | NEGATIVE | 3 | 9 | 126 |
| 1187 | NEPHROLOGY | 3 | 1 | 16 |
| 1188 | NEPHROTIC | 3 | 5 | 20 |
| 1189 | NEPHROTOXIC | 3 | 11 | 101 |
| 1190 | NETWORK | 3 | 4 | 36 |
| 1191 | NEURONAL | 3 | 1 | 47 |
| 1192 | NEUROPROTECTION | 3 | 11 | 147 |
| 1193 | NEUROTOXICITY | 3 | 6 | 96 |
| 1194 | NEWBORN | 3 | 3 | 16 |
| 1195 | NITRIC | 3 | 0 | 16 |
| 1196 | NUCLEAR-MAGNETIC-RESONANCE | 3 | 2 | 54 |
| 1197 | NUCLEIC | 3 | 1 | 28 |
| 1198 | NUMBER | 3 | 8 | 363 |
| 1199 | OXIDE | 3 | 0 | 16 |
| 1200 | PARENTAL | 3 | 12 | 50 |